Piramal Pharma Limited finalise l'acquisition d'une participation majoritaire dans Yapan Bio Private Limited

Positive

AI Analysis

Summary

Piramal Pharma Limited finalized acquisition of majority stake in Yapan Bio Private Limited, a company specializing in Phase I and II vaccine and biologics manufacturing services, process development, and characterization compliant with GMP standards.

Outcome Details

Piramal Pharma Limited finalized acquisition of majority stake in Yapan Bio Private Limited

Importance:6/10

Sentiment:

0.50

M&Aacquisitionmajority stakevaccine manufacturingbiologics CDMOGMP

Read the original article

Published by PR Newswire Biotech on August 19, 2026 3:21 PM

Read Original